NCT06305351: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
- State
- Completed
- Phase
- Phase 1
- People
- 25 taking part
- Started
- 7 Dec 2023
- Primary completion
- 15 May 2024
- Arms
- K-757 and K-833 combination
- Results
- None posted
- 7 Dec 2023: Trial started
- 12 Mar 2024: Trial registered
- 21 Jun 2024: Trial completed